Title

Different Responses to 5-fluoraouracil in Mutagenicity and Gene Expression between Two Human Lymphoblastoid Cell Lines with or without TP53 Mutation

Author(s)

Hiroaki Oka Tokushima Research Center, Taiho pharmaceutical Co., Ltd.
Mamoru Ouchida Department of Molecular Genetics, Okayama University Graduate School of Medicine
Takuya Kondo Tokushima Research Center, Taiho pharmaceutical Co., Ltd.
Fumio Morita Tokushima Research Center, Taiho pharmaceutical Co., Ltd.
Kenji Shimizu Department of Molecular Genetics, Okayama University Graduate School of Medicine

Publication Date

2012-04

Abstract

Human lymphoblastoid TK6 and WTK-1 cells are widely used to detect mutagens in vitro. TK6 cells have wild-type TP53 alleles, while WTK-1 cells have one allele of mutated TP53. Both cells were treated with 5-fluorouracil (5-FU), and gene mutation assay and micronucleus assay were performed to clarify the differential response related to the TP53 gene status. The effects of 5-FU on gene expression were assessed by microarray and quantitative RT-PCR analyses. In WTK-1 cells, 5-FU increased the frequency of cells with micronucleus and mutation. In TK6 cells, frequency of cells with micronucleus was increased but the mutation frequency was not. The cytotoxicity induced by 5-FU was more prominent in TK6 cells than in WTK-1 cells. Analysis of gene expression showed that the genes involved in the TP53 pathway were up-regulated in TK6 cells but not in WTK-1 cells. The differential responses to 5-FU between these cell lines appeared to be due to the difference in the TP53 gene status, thus providing a molecular basis for the bioassays using these cell lines in the toxicology field. Our results indicate that the clinical efficacy of 5-FU chemotherapy may depend on the TP53 genotype.

Document Type

Original Article

Keywords

5-fluorouracil
TP53
Tk mutation assays
microarray analysis

Link to PubMed

22525470